Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
KIR3DL1 Antibody, AMB11 Antibody, CD158E1 Antibody, CD158e antigen Antibody, CD158E Antibody, CD158e1/2 Antibody, CD158e2 Antibody, Cl-11 Antibody, KIR antigen 3DL1 Antibody, MHC class I NK cell receptor Antibody, NK-receptor Antibody, NKB1 Antibody, KIR Antibody, KIR3DL1/S1 Antibody, NKB1B Antibody, Cl-2 Antibody, Killer Ig receptor Antibody, NKAT-3 Antibody, NKAT3 Antibody, p70 NK receptor CL-2/CL-11 Antibody
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2).
Western blot of Human 293T. KIR3DL1 antibody dilution 1.0 ug/ml. This image was taken for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.
Requested From: United States
Date Requested: 10/25/2016